🕒 Wednesday 29 July 2026 Wed, 29 July 2026

Artrya is advancing its commercial footprint in the US with two health systems now generating revenue and FDA clearance for its Salix Coronary Flow module expected in H2 2026.

Sea Forest Limited accelerated its commercial momentum in 4Q26 with an 83% revenue increase to $2.1 million, underpinned by new cattle supply agreements and the commissioning of its first regional distribution centre in Newcastle.

Gateway Mining has ramped up exploration at its Cowza gold discovery with a second RC rig, confirming continuous high-grade gold mineralisation along a 3.5-kilometre strike that remains open in multiple directions.

Lion Rock Minerals has appointed a new leadership team with Sierra Rutile pedigree to drive development at its Minta Monazite & Rutile Project in Cameroon, backed by strong drilling results and a $2 million capital raise.

Lux Copper has completed its first-ever geophysical survey at the Baird Copper Project in Alaska and is mobilizing two diamond drill rigs ahead of a maiden drilling campaign set for mid-August 2026.

xReality Group delivered a robust Q4 FY26, with cash receipts up 46% to $6.9 million and net operating cash flow rising 64% to $2.2 million. The company completed a $5.6 million US Department of Defense project on time and secured its first European contract with the Swedish Armed Forces.

IRIS Metals is gearing up for a substantial tungsten drilling campaign in Montana while delivering a fresh lithium-rubidium resource estimate for its South Dakota project, underpinning its North American critical minerals ambitions.

Many Peaks Minerals has reported a landmark maiden Mineral Resource Estimate of 1.32 million ounces at its Ferké Gold Project, underpinning an aggressive exploration and development push supported by a A$27.5 million capital raise.

FMR Resources reports encouraging assay results from its maiden drill program at the Llahuin JV, revealing extensive copper-gold-molybdenum mineralisation. The company also progresses its acquisition of the La Lorena Project with high-grade rock chip samples and identifies multiple magnetic targets for follow-up.

Cyclopharm’s Technegas® has been named the preferred ventilation agent in new US lung imaging guidelines, marking the first update in 14 years and potentially accelerating adoption across American hospitals.

Saluda Medical capped FY26 with a 28% revenue surge, beating guidance at US$90.2 million, while FDA approval for its CAP24 paddle lead opens a new US surgical market segment.

Prospect Resources has boosted its Mumbezhi Copper Project resource by 20%, notably doubling gold content, while commencing an extensive Phase 3 drilling program aimed at further expansion and upgrading.

Horizon Oil achieved record production and sales in FY26, driven by its Thailand assets, and completed the off-market takeover of Cue Energy, expanding its footprint across five countries.

Alkane Resources has expanded its Storheden gold resource near the Björkdal mine in Sweden, adding Indicated Resources and increasing contained gold by 26%. Recent drilling revealed high-grade veins along a 2.7 km strike, with mineralisation still open in multiple directions.

DXN Limited has landed a $1.2 million contract for a key Pacific submarine cable project while advancing its maiden AI HPC modular data centre deal and expanding manufacturing in Southeast Asia.

Regener8 Resources (ASX:R8R) has finalised its 100% acquisition of the Srebrenica North polymetallic project in Bosnia and Herzegovina, initiated a systematic soil sampling program, and raised $1.415 million through a non-renounceable entitlement offer to fund exploration and working capital.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.

D3 Energy has expanded its helium resource base significantly in South Africa, certifying a maiden contingent resource at ER386 that boosts combined helium resources by 65%. The company also certified its first Australian prospective resource and started drilling at Nooitgedacht in ER315.

Vitrafy Life Sciences reported a breakthrough 94.4% post-thaw platelet recovery in US Army Phase II testing, secured major US blood network partnerships, and raised $32 million to accelerate US expansion and device manufacturing.

Adherium Limited has posted a fourth consecutive quarter of record remote patient monitoring revenue, driven by growing device activations and strong clinical evidence from the iCARE study, positioning the company for expanded value-based care contracts in the US.

DeSoto Resources has launched a 10,000m maiden drilling program at its Timbakouna Gold Project and secured a major new ground package in Guinea’s prolific Siguiri Basin, backed by a strong cash position of A$9.2 million.

OD6 Metals has revealed gold assays up to 6.31g/t at its Quinn Fluorspar Project in Nevada, highlighting a large epithermal mineral system with potential for both epithermal and Carlin-style gold deposits alongside its core fluorspar targets.

Nexus Minerals has completed its Branches Prospect drilling campaign with strong assay results confirming continuity of a northwest-trending gold system. These findings position Branches alongside Clement and Payns to contribute to an updated Wallbrook Mineral Resource Estimate due in September.

Greatland Resources (ASX:GGP) exceeded its FY26 production and cost guidance, delivering 329koz of gold at a $2,179/oz AISC and bolstering cash to $1.29 billion. The company advanced key growth projects at Havieron and Telfer, including a major reserve upgrade and promising drilling results at Pinnacles.